Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Busch

Showing results (701-710 of 1,108) with videos related to

Pageof 111
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cellsAntje Heit, Tobias Maurer, Hubertus Hochrein, et al.
Journal of Chromatography. A|September 13, 1996
Critical evaluation of the applicability of capillary zone electrophoresis for the study of hapten-antibody complex formationM H Busch, H F Boelens, J C Kraak, et al.
Biochemical and Biophysical Research Communications|July 30, 1981
Diversity of rat strains and tumor lines of DNA fragments homologous to an amplified 5.8 kilobase ECO R1 fragment of Novikoff hepatoma cellsL I Rothblum, D L Parker, B Cassidy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccinesAntje Heit, Frank Schmitz, Meredith O'Keeffe, et al.
European Journal of Immunology|December 2, 2022
Single-cell fate mapping reveals widespread clonal ignorance of low-affinity T cells exposed to systemic infectionJustin Leube, Anton Mühlbauer, Immanuel Andrä, et al.
Journal of the American Chemical Society|December 25, 2003
A superoxo-ferrous state in a reduced oxy-ferrous hemoprotein and model compoundsRoman Davydov, James D Satterlee, Hiroshi Fujii, et al.
Clinical Immunology and Immunopathology|February 1, 1981
Results of a preliminary "blind" study on the presence of the human tumor nucleolar antigen in breast carcinomas, benign breast tumors, and normal breast tissuesH Busch, R K Busch, P K Chan, et al.
Biochemical and Biophysical Research Communications|February 28, 1979
Amino terminal amino acid sequence of macromomycin, a protein antitumor antibioticT H Sawyer, K Guetzow, M O Olson, et al.
Journal of Translational Autoimmunity|January 2, 2023
Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective studyRenée Ysermans, Matthias H Busch, Joop P Aendekerk, et al.
Journal of the American Chemical Society|November 13, 2008
Oxidative reactivity difference among the metal oxo and metal hydroxo moieties: pH dependent hydrogen abstraction by a manganese(IV) complex having two hydroxide ligandsGuochuan Yin, Andrew M Danby, David Kitko, et al.
Pageof 111

Showing results (701-710 of 1,108) with videos related to

Sort By:
Pageof 111
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cellsAntje Heit, Tobias Maurer, Hubertus Hochrein, et al.
Journal of Chromatography. A|September 13, 1996
Critical evaluation of the applicability of capillary zone electrophoresis for the study of hapten-antibody complex formationM H Busch, H F Boelens, J C Kraak, et al.
Biochemical and Biophysical Research Communications|July 30, 1981
Diversity of rat strains and tumor lines of DNA fragments homologous to an amplified 5.8 kilobase ECO R1 fragment of Novikoff hepatoma cellsL I Rothblum, D L Parker, B Cassidy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccinesAntje Heit, Frank Schmitz, Meredith O'Keeffe, et al.
European Journal of Immunology|December 2, 2022
Single-cell fate mapping reveals widespread clonal ignorance of low-affinity T cells exposed to systemic infectionJustin Leube, Anton Mühlbauer, Immanuel Andrä, et al.
Journal of the American Chemical Society|December 25, 2003
A superoxo-ferrous state in a reduced oxy-ferrous hemoprotein and model compoundsRoman Davydov, James D Satterlee, Hiroshi Fujii, et al.
Clinical Immunology and Immunopathology|February 1, 1981
Results of a preliminary "blind" study on the presence of the human tumor nucleolar antigen in breast carcinomas, benign breast tumors, and normal breast tissuesH Busch, R K Busch, P K Chan, et al.
Biochemical and Biophysical Research Communications|February 28, 1979
Amino terminal amino acid sequence of macromomycin, a protein antitumor antibioticT H Sawyer, K Guetzow, M O Olson, et al.
Journal of Translational Autoimmunity|January 2, 2023
Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective studyRenée Ysermans, Matthias H Busch, Joop P Aendekerk, et al.
Journal of the American Chemical Society|November 13, 2008
Oxidative reactivity difference among the metal oxo and metal hydroxo moieties: pH dependent hydrogen abstraction by a manganese(IV) complex having two hydroxide ligandsGuochuan Yin, Andrew M Danby, David Kitko, et al.
Pageof 111